Chief Medical Officer of G1 Therapeutics, Inc. (NASDAQ:GTHX), Malik Rajesh, sells 15,000 shares worth $344,192
According to G1 Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Mar 04 05:10 PM, company Chief Medical Officer, Malik Rajesh disclosed selling 15,000 shares at a cost of $22.95. At the time of this transaction (Mar 02), this trade was worth $344,192 in total. As of Mar 02, Malik Rajesh now owns 43,300 shares in total worth about $879,423.0.
For the last few recent trades made by G1 Therapeutics, Inc. (NASDAQ:GTHX) Chief Medical Officer, Malik Rajesh, we have the following information:
- SEC Form 4 filing: Dec 10: Sold 9,000 shares at the rate of $20.06 per share. Total worth of this trade was $180,550. Total number of shares owned as of Dec 10 were 29,200
Posted by
George Daniels
on Thursday March 04 2021, 6:59 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
